Drug Approval | May 06, 2024
Briefs: Eugia Pharma Specialities and IOL Chemicals and Pharmaceuticals
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
These observations are procedural in nature and will be responded within the stipulated time
The observations are procedural in nature and will be responded to within the stipulated time
Highly effective preservation solutions ensuring the safety and protection of personal care products
WINREVAIR is a breakthrough biologic for this rare, progressive disease
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
Nectar Lifesciences has clarified that the company has no relation/connection/ association or link of any nature with the Nectar Herbs and Drugs
Subscribe To Our Newsletter & Stay Updated
